Sanofi (ENXTPA: SAN) reported earnings on May 2. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Sanofi missed estimates on revenues and whiffed on earnings per share.
Compared to the prior-year quarter, revenue dropped. Non-GAAP earnings per share dropped significantly. GAAP earnings per share dropped significantly.
Margins dropped across the board.
Sanofi booked revenue of $10.33 billion. The nine analysts polled by S&P Capital IQ foresaw sales of $10.60 billion on the same basis. GAAP reported sales were 12% lower than the prior-year quarter's $11.91 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.56. The nine earnings estimates compiled by S&P Capital IQ forecast $1.74 per share. Non-GAAP EPS of $1.56 for Q1 were 37% lower than the prior-year quarter's $2.47 per share. GAAP EPS of $0.97 for Q1 were 47% lower than the prior-year quarter's $1.84 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 68.9%, 170 basis points worse than the prior-year quarter. Operating margin was 19.5%, 650 basis points worse than the prior-year quarter. Net margin was 12.3%, 810 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $11.48 billion. On the bottom line, the average EPS estimate is $1.90.
Next year's average estimate for revenue is $46.76 billion. The average EPS estimate is $7.83.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Sanofi is outperform, with an average price target of $102.52.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Sanofi. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Sanofi to My Watchlist.